Procardia and Multiple myeloma - a phase IV clinical study of FDA data

Summary:

Multiple myeloma is reported as a side effect among people who take Procardia (nifedipine), especially for people who are male, 60+ old, also take Revlimid, and have Nausea.

The phase IV clinical study analyzes which people have Multiple myeloma when taking Procardia. It is created by eHealthMe based on reports of 14,828 people who have side effects when taking Procardia from the FDA, and is updated regularly.

What is Procardia?

Procardia has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 15,151 Procardia users. Check the latest studies of Procardia.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

On Aug, 11, 2026

14,828 people reported to have side effects when taking Procardia.
Among them, 44 people (0.3%) have Multiple myeloma.

Among these 44 people:

What is the gender of people who have Multiple myeloma when taking Procardia? *

female: 38.64 %
male: 61.36 %

What is the age of people who have Multiple myeloma when taking Procardia? *

What are other drugs people take besides Procardia? *

What are other side effects people have besides Multiple myeloma? *

Back Pain: 10 people, 22.73%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 20.45%
Acute Kidney Failure: 9 people, 20.45%
Anaemia (lack of blood): 9 people, 20.45%
Pain: 8 people, 18.18%
Stress And Anxiety: 7 people, 15.91%
Swallowing Difficulty: 7 people, 15.91%
Osteonecrosis Of Jaw (death of bone of jaw): 7 people, 15.91%
Primary Sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone): 7 people, 15.91%
Confusional State: 7 people, 15.91%

What are the existing conditions these people have? *

Sleep Disorder: 3 people, 6.82%
Disease Progression: 3 people, 6.82%
Nausea (feeling of having an urge to vomit): 3 people, 6.82%
Joint Pain: 2 people, 4.55%
Constipation: 2 people, 4.55%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 4.55%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 4.55%
Hypersensitivity: 2 people, 4.55%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 4.55%
Anaemia (lack of blood): 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia and have Multiple myeloma?

- Check whether Multiple myeloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procardia:

Procardia (15,151 reports)

Multiple myeloma treatments and more:

Multiple myeloma (516,725 reports)

Browse all side effects of Procardia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple myeloma:

Multiple myeloma (1,107 drugs)

Browse all the conditions that are associated with Multiple myeloma:

Multiple myeloma (1,404 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia) and Procardia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.